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Objectives: In this study we investigate the relationships between placental size and neonatal bone mass
and body composition, in a population-based cohort.
Study design: 914 mothereneonate pairs were included. Placental dimensions were measured via
ultrasound at 19 weeks gestation. Dual X-ray absorptiometry (DXA) was performed on the neonates
within the ﬁrst two weeks of life.
Results: We observed positive relationships between placental volume at 19 weeks, and neonatal bone
area (BA; r ¼ 0.26, p < 0.001), bone mineral content (BMC; r ¼ 0.25, p < 0.001) and bone mineral density
(BMD; r ¼ 0.10, p ¼ 0.001). Thus placental volume accounted for 6.25% and 1.2% of the variation in
neonatal BMC and BMD respectively at birth. These associations remained after adjustment for maternal
factors previously shown to be associated with neonatal bone mineral accrual (maternal height, smoking,
walking speed in late pregnancy, serum 25(OH) vitamin D and triceps skinfold thickness).
Conclusions: We found that placental volume at 19 weeks gestation was positively associated with
neonatal bone size and mineral content. These relationships appeared independent of those maternal
factors known to be associated with neonatal bone mass, consistent with notion that such maternal
inﬂuences might act through modulation of aspects of placental function, e.g. utero-placental blood ﬂow
or maternal nutrient concentrations, rather than placental size itself. Low placental volume early in
pregnancy may be a marker of a reduced postnatal skeletal size and increased risk of later fracture.
 2012 Elsevier Ltd. Open access under CC BY license.1. Introduction
Osteoporosis is a major cause of morbidity and mortality
through its association with age-related fractures. Bone size and
density appear to track throughout childhood to peak in early
adulthood, and this peak bone mass has been shown to be a major
determinant of osteoporosis risk in later life [1].We have previously
demonstrated that growth in utero and early childhood predict
adult bone mineral content (BMC) [2,3] and risk of hip fracture infax: þ44 0 23 8070 4021.
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BY license.later life [4]. Maternal factors such as smoking, body build, physical
activity, diet [5] and circulating 25(OH) vitamin D status [6] during
pregnancy are associated with offspring bone mineral accrual.
During the period of a normal human pregnancy the fetus accu-
mulates approximately 30 g of calcium [7]. This fetal demand is met
through placental calcium transport, which results in a higher
calcium concentration in fetal than maternal blood [8]. We have
previously demonstrated that the expression of a placental calcium
transporter (PMCA3) gene predicts neonatal bone mineral content
[9], but it remains unclear whether the maternal inﬂuences
described act on fetal bone development via placental size or
function.
In this study we investigate the relationships between placental
dimensions, measured by ultrasound scanning, and offspring body
composition, bone size and density assessed by dual x-ray
absorptiometry (DXA) at birth, using a longitudinal population-
based mother-offspring cohort, the Southampton Women’s
Survey (SWS).
C.R. Holroyd et al. / Placenta 33 (2012) 623e6296242. Methods
2.1. Participants
Details of the SWS have been published previously [10]. In brief, 12,583 non-
pregnant women aged 20e34 years were recruited via their general practitioners.
Assessments of lifestyle, diet (by validated food frequency questionnaire) and
anthropometry were performed at study entry and then in early (11 weeks) and late
(34 weeks) gestation in those women who became pregnant. Maternal social class
was also measured via questionnaire. Maternal height wasmeasured pre-pregnancy
with a stadiometer (Seca, Birmingham, UK), weight with calibrated digital scales
(Seca, Birmingham, UK) and skin folds (biceps, triceps, subscapular and supra-iliac)
with Harpenden callipers (Baty International, Sussex, UK). Serum 25(OH) Vitamin D
was measured in late pregnancy (Diasorin Liaison RIA, Minnesota, USA). Women
were asked to characterise their walking speed into one of ﬁve categories (very slow,
stroll at an easy pace, normal speed, fairly brisk or fast) as a marker of overall
physical activity. The women’s own birth weight was recorded (by recall, checked,
where possible, by asking her to consult her own parents).
2.2. Prenatal ultrasound scanning
3159 singleton pregnancies were followed. At 19 weeks gestation, the women
underwent high-resolution ultrasound scanning using an Acuson Sequoia 512
system (Siemens, Malvern, PA, USA) with a 5e8 MHz curvelinear transducer. After
establishing correct positioning according to standard anatomical landmarks,
measurements of placental section perimeter, length of attachment to the uterine
wall and cross-sectional area were made on the frozen two-dimensional images
using electronic callipers by an experienced sonographer (either PM or CN)e (Fig.1).
The sonographer measured the placenta in two planes, initially along the longest
edge of attachment to the uterine wall (length) and then at 90 to this, so that the
image plane bisected the longitudinal axis (breadth). Each measurement was per-
formed in triplicate and themean value used for analysis. Placental volumewas later
calculated using the two-dimensional ultrasound measurements. To estimate the
volume of the placenta we assumed that it was an ellipsoid. The two measured
section perimeters and two areas were expressed as functions of the three ellipsoid
radii. Estimates of the radii, obtained by least squares, were then combined to
estimate the volume. This method demonstrated good correlation with placental
volume measured by 3D ultrasound (Kretz Voluson 730 (r ¼ 0.64, p < 0.0001)) in
a sub-set of 28 pregnancies at mean 19.9 (0.4) weeks gestation.
2.3. Neonatal DXA assessment
Mothers registered with speciﬁc general practices were invited to participate in
the bone component of the SWS. These practices were selected to avoid the mothers
participating inmore than one sub-study, and were representative of the population
Southampton as a whole. At birth, the babies were weighed on calibrated digital
scales (Seca, UK). The mother was asked to give written informed consent for herFig. 1. A 19 week ultrasound scan showing placental size measurements in the
longitudinal plane.baby to undergo assessment of bone mass and body composition within 2 weeks of
birth, using a DXA scanner with speciﬁc paediatric software (Lunar DPX-L paediatric
small scan mode v 4.7c, GE Corporation, Madison, Wisconsin, USA). The instrument
underwent daily quality assessment and was calibrated against a water phantom
weekly.
At the visit to the scan room, the baby was paciﬁed and fed if necessary,
undressed completely, and then swaddled in a standard towel. Measurement of
whole body bone area (BA), bone mineral content (BMC), areal bone mineral density
(aBMD) and body composition were performed (total and proportionate fat and
lean). The short-term and long-term coefﬁcients of variation (CV) for adult whole
body BMD for the DXA instrument were 0.8% and 1.4% respectively. The radiation
exposure to the baby was estimated as a maximum of 8.9 microsieverts for whole
body measurement, which is equivalent to 3 days’ exposure to normal background
radiation. All DXA scans were reviewed and those with movement artefact (41
scans) were excluded from the study.
2.4. Statistical analysis
Gestational age was determined using an algorithm combining last menstrual
period and early ultrasound data. All variables were checked for normality. Neonatal
total fat mass, proportionate lean mass and proportionate fat mass were not nor-
mally distributed and were transformed using a FishereYates transformation
(standard deviate units). Unpaired t-tests were used to compare unstandardized
neonatal characteristics by sex. A ManneWhitney U test was used if assumptions of
normality were not met.
Pearson correlation and linear regression were used to relate placental
measurements to neonatal body composition and bone size and density. We then
explored whether previously identiﬁed maternal determinants of neonatal bone
mass might be mediated via placental measurements using multivariate linear
regression. Stata V11.1 (StataCorp LP, College Station, TX) was used for all analyses.
Bone outcomes used included whole body BA, BMC and aBMD. To adjust for body
size we used size corrected BMC (BMC adjusted for BA, and the baby’s length and
weight (scBMC)). DXA measurements were associated with the square of offspring
age at the scan, consistent with the known tendency of infants to lose weight
transiently over the ﬁrst week of postnatal life. Thus, all neonatal outcomes were
adjusted for gestational age, sex and the square of the age at DXA; birth weight was
adjusted for gestational age. The ultrasound-derived placental measures were also
adjusted for gestational age at which the measurement was taken using the method
of Royston and subsequently standardized to z-scores [11].
The study had full ethical approval from the Southampton and Southwest
Hampshire Local Research Ethics Committee and all participants gave written
informed consent.
3. Results
3.1. Characteristics of the mothers and neonates
Of the 3159 participants, 914 had complete 19 week ultrasound
and neonatal DXA data, and delivered after 37 weeks gestation.
Baseline characteristics of the women are shown in Table 1(a). The
median (IQR) age of themothers at the birth of their babies was 31.1
(28.0e33.8) years. Their mean (SD) height was 163.4 (6.3) cm and
median (IQR) BMI pre-pregnancy was 24.2 (22.0e27.5) kg/m2.
The baseline characteristics of the 914 (474 male) neonates are
shown in Table 1(b). The boys tended to be heavier at birth, with
higher BA, BMC and aBMD. All outcome measures were therefore
adjusted for infant’s sex.
Compared with mothers of children born to the SWS cohort
during the same time frame but who did not have placental
measurements at 19 weeks or a neonatal DXA scan, the mothers in
this study were more highly educated (24.5% versus 21.2%
achieving a higher degree, p¼ 0.10) andwere less likely to smoke in
pregnancy, although this did not achieve statistical signiﬁcance
(17.6% vs. 21.7%, p ¼ 0.06). There were no differences in maternal
age at child’s birth, maternal height, BMI or smoking before preg-
nancy between the two groups.
3.2. Placental ultrasound measurements at 19 weeks and neonatal
body composition
Table 2 summarises the relationships between placental
measurements and offspring body composition and bone size and
Table 1
Characteristics of mothers and neonates.
A) Maternal characteristics n ¼ 914
Age at child’s birth (yr) 31.1 (28.0e33.8)
Height (cm) 163.4 (6.3)
BMI pre-pregnancy (kg/m2) 24.2 (22.0e27.5)
Triceps skinfold at 34 weeks (mm) 20.6 (16.7e25.6)
Parity
0 480 (52.5%)
1 or more 434 (47.5%)
Smoking before pregnancy
No 665 (72.8%)
Yes 249 (27.2%)
Smoking at 34 weeks
No 760 (86.6%)
Yes 118 (13.4%)
Walking speed at 34 weeks
Very slow 139 (16.2%)
Stroll 433 (50.5%)
Normal speed 230 (26.5%)
Fairly brisk 52 (6.1%)
Fast 3 (0.4%)
Serum 25(OH) Vitamin D at 34 weeks (nmol/l) 63.9 (44.0e87.0)
Placental circumferencea at 19 weeks (cm) 29.5 (27.2e32.2)
Placental circumferenceb at 19 weeks (cm) 29.2 (26.7e38.9)
Placental length of attachmenta at 19 weeks (cm) 15.6 (14.1e17.4)
Placental length of attachmentb at 19 weeks (cm) 15.6 (14.0e22.4
Placental cross-sectional areaa at 19 weeks (cm2) 24.4 (21.0e28.5)
Placental cross-sectionalb at 19 weeks (cm2) 24.3 (20.6e28.9)
Placental volume at 19 weeks (cm3) 230.1 (192.7e277.9)
B) Neonatal characteristics
Boys n ¼ 474 Girls n ¼ 440 p Diff
Birth weight (kg) 3.59 (0.5) 3.49 (0.5) 0.002
Gestational age (weeks) 40.1 (1.2) 40.3 (1.2) 0.01
Gestational age at time of scan (weeks) 19.6 (0.6) 19.6 (0.5) 0.7
Birth crown-heel length (cm) 50.5 (1.9) 49.7 (1.9) <0.001
Age at DXA (days) 6.4 (2e11) 6.5 (2e12) 0.69
Whole body bone area (cm2) 121.4 (25.3) 118.0 (24.9) 0.001
Whole body BMC (g) 65.0 (15.6) 61.3 (15.1) <0.001
Whole body aBMD (g/cm2) 0.5 (0.03) 0.5 (0.3) <0.001
Size corrected BMC (g) 62.4 (2.9) 61.8 (2.9) 0.003
Total lean mass (g) 3026.6 (358.8) 2884.9 (323.7) <0.001
Total fat mass (g) 507.7 (382.4e655.6) 533.3 (403.5e694.6) 0.01
%Lean mass (%) 84.2 (81.2e87.3) 83.0 (79.6e85.6) <0.001
%Fat mass (%) 13.9 (11e16.9) 15.3 (12.7e18.5) <0.001
Data are mean (SD), median (IQR) or number (%).
a Measured along the longest edge of attachment to the uterine wall (length).
b Placenta measured perpendicular to the longest edge of attachment to the uterine wall (breadth).
C.R. Holroyd et al. / Placenta 33 (2012) 623e629 625density. We observed strong positive relationships between each of
placental section perimeter, length of attachment to the uterine
wall and cross-sectional area at 19 weeks and neonatal BA and BMC
(all p < 0.001). However, there was some disparity in theTable 2
Relationship between placental size and neonatal bone mass and body composition.
BA (cm2) BMC (g) aBMD (g/cm2) BA adjusted for
crown-heel leng
r r r r
Placental measurements at 19 weeks
Section perimetera (z) 0.15*** 0.13*** 0.04 0.07*
Length of attachmenta (z) 0.12*** 0.11*** 0.04 0.06
Cross-sectional areaa (z) 0.18*** 0.17*** 0.05 0.09*
Section perimeterb (z) 0.20*** 0.19*** 0.11** 0.14***
Length of attachmentb (z) 0.16*** 0.16*** 0.09** 0.13***
Cross-sectional areab (z) 0.22*** 0.21*** 0.11*** 0.14***
Volume (z) 0.26*** 0.25*** 0.11** 0.16***
Table shows Pearson’s correlation coefﬁcients (r) from univariate regression analyses.
*p < 0.05, **p < 0.01, ***p < 0.001.
a Measured along the longest edge of attachment to the uterine wall (length).
b Measured perpendicular to the longest edge of attachment to the uterine wall (brearelationship between neonatal aBMD and these placental
measurements depending on the plane of placental measurement;
a positive association was seen between placental measurements
and aBMD when the placenta was measured along its breadth (pth (cm2)
Size corrected
BMC (g/cm2)
Total lean (g) Total fat (z) %Lean (z) %Fat (z)
r r r r r
0.03 0.14*** 0.12*** 0.10*** 0.09**
0.03 0.11** 0.09** 0.08* 0.07*
0.01 0.18*** 0.18*** 0.15*** 0.15***
0.006 0.16*** 0.16*** 0.14*** 0.14***
0.008 0.10** 0.13*** 0.13*** 0.13***
0.02 0.18*** 0.19*** 0.18*** 0.17***
0.001 0.23*** 0.23*** 0.20*** 0.19***
dth).
C.R. Holroyd et al. / Placenta 33 (2012) 623e629626all < 0.01), but no association was seen when the placenta
measured along its longest axis (length).
Placental volume correlated positively with neonatal BA, BMC
and aBMD (p all < 0.01) and neonatal BA adjusted for crown-heel
length (r ¼ 0.15, p < 0.001). Thus, for every 1 SD increase in
placental volume, BA increased by 6.2 cm2, BMC increased by 3.6 g,
aBMD increased by 0.0029 g/cm2 and BA adjusted for crown-heel
length increased by 2.9 cm2 (Fig. 2). No signiﬁcant association
was observed between placental size and neonatal size corrected
BMC (all p > 0.36).
Placental volume at 19 weeks was positively associated with
neonatal total lean mass (r ¼ 0.23, p < 0.0001) and fat mass
(r ¼ 0.23, p < 0.0001). There was a different pattern with propor-
tionate body composition. Thus, placental volume was positively
related to percent fat (r ¼ 0.19, p < 0.0001) but negatively to
percent lean (r ¼ 0.20, p < 0.0001), indicating that as placental
volume increased, total neonatal size increased, but with an
increase in percentage fat and a reduction in percentage leanwithin
the overall size envelope (Fig. 3).
We performed a sensitivity analysis by removing extreme values
(excluding those participants with placental volume > 500 mm3,
total lean mass < 2200 g, percent lean < 70 and percent fat > 30)
and the strongly signiﬁcant relationships remained with little or no
change in r value (Pearson correlation coefﬁcient for association
with placental volume: total lean mass, r ¼ 0.2, p < 0.00001; total
fat mass, r ¼ 0.23, p < 0.00001; percent lean, r ¼ 0.17,
p < 0.00001; percent fat, r ¼ 0.18, p < 0.00001).
All associations remained after adjustment for maternal factors
previously shown to affect neonatal bone mineral accrual (parity,
smoking, walking speed, maternal serum 25(OH) vitamin D and
maternal triceps skinfold thickness in pregnancy). In addition, the
relationship between placental size and offspring bone mass was
adjusted for maternal height, as maternal body build tends to be
collinear with placental size, and although this attenuated some
results, the relationships remained statistically signiﬁcant (Table 3).
Relationships between placental and DXA measurements were
similar in boys and girls, with all placental measurement/sex
interactions on bone outcomes failing to achieve statistical signif-
icance (p > 0.05).
We calculated the ratio of placental volume: birth weight as
a marker of placental “efﬁciency”. This was positively associated
with neonatal BA and BMC (p< 0.01), however after adjustment for
maternal factors known to affect neonatal bone mineral accrual,
signiﬁcant associations were no longer seen.Fig. 2. Association between placental volume at 19 weeks and neonatal bone mass Scatter-p
19 weeks, and neonatal bone mass measured by dual x-ray absorptiometry (DXA). Placental v
SD increase in placental volume, BA increased by 6.2 cm2, BMC increased by 3.6 g, aBMD in
Placental volume adjusted for gestational age. BA, BMC, BMD adjusted for sex, gestational3.3. Maternal characteristics and placental size
Several maternal factors were positively correlated with
placental volume at 19 weeks (Table 4). Placental volume was
positively associated with maternal height (r ¼ 0.09, p ¼ 0.007),
body fat pre-pregnancy (r ¼ 0.11, p ¼ 0.001) and age at child’s birth
(r¼ 0.07, p¼ 0.03). Smoking, 25(OH) vitamin D status, parity, social
class and walking speed pre-pregnancy were not statistically
signiﬁcantly associated with placental volume.
4. Discussion
To our knowledge, this is the ﬁrst study to relate ultrasound
measurements of mid-pregnancy placental size to postnatal infant
bone mass and body composition measured by DXA. Placental
section perimeter, length of attachment and volume were posi-
tively associated with offspring intrauterine bone mineral accrual.
An association betweenmid-pregnancy placental size and neonatal
body composition was also observed; thus greater placental
volume was associated with greater birth weight, higher
percentage fat and lower percentage lean. These relationships
appeared independent of maternal height and other factors (parity,
smoking, walking speed, maternal serum 25(OH) vitamin D and
maternal triceps skinfold thickness in pregnancy) known to inﬂu-
ence neonatal bone mass, consistent with the notion that these
maternal factors may act through modulation of aspects of
placental function, such as utero-placental blood ﬂow or maternal
nutrient concentrations, rather than size alone.
This was a large prospective study, with detailed characteriza-
tion of the mothers and babies, using a validated measure of bone
mineral. However, several limitations should be considered in the
interpretation of our results. First, intrauterine ultrasound
measurements are prone to reproducibility error; however the
scans were performed by two experienced sonnographers
following standard guidelines. Second, although the use of DXA is
well established in adults, there are limitations to its use in
neonates due to their tendency to move and their low absolute
BMC. Speciﬁc paediatric softwarewas used tominimise loss of edge
detection, and movement artefact was modest and uniform across
the cohort. Babies with excessive movement were excluded from
the analysis. It was not possible to perform repeat DXA assessments
on the neonates to determine values for the coefﬁcient of variation
of DXA in children. However, DXA measurements of bone mass
have been shown to correlate well with whole body calciumlots illustrating the relationship between placental volume, measured by ultrasound at
olume correlated positively with neonatal BA, BMC and aBMD (p all < 0.01). For every 1
creased by 0.0029 g/cm2 and BA adjusted for crown-heel length increased by 2.9 cm2.
age and square of age at scan. WB: whole body
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Fig. 3. Association between placental volume at 19 weeks and neonatal fat and lean mass Scatter-plots illustrating the relationship between placental volume, measured by
ultrasound at 19 weeks, and neonatal bone mass measured by dual x-ray absorptiometry (DXA). Placental volume at 19 weeks was positively associated with neonatal total lean
mass (r ¼ 0.23, p < 0.0001) and fat mass (r ¼ 0.23, p < 0.0001). There was a different pattern with proportionate body composition. Thus, placental volume was positively related to
percent fat (r ¼ 0.19, p< 0.0001) but negatively to percent lean (r ¼ 0.20, p< 0.0001). Volume adjusted for gestational age. Lean mass and fat mass adjusted for sex, gestational age
and square of age at scan
C.R. Holroyd et al. / Placenta 33 (2012) 623e629 627content in studies of small animals such as piglets [12]. We have
reported on a sub-set of the original SWS births. On average the
mothers included in this study were better educated and were
slightly less likely to smoke in pregnancy compared with SWS
mothers of babies who were not assessed by ultrasound at 19
weeks nor had neonatal DXA measurements. However, as the
observations we report are based on internal comparisons, there is
no reason to suppose that this would have biased the results. TheTable 3
Relationship between placental size and neonatal bone mass and body composition, adj
BA (cm2) BMC (g) aBMD (g/cm2) BA adjusted for
crown-heel len
r r r r
Section perimetera(z) 0.15 *** 0.13 *** 0.03 0.07*
Length of attachmenta (z) 0.15 *** 0.13 *** 0.04 0.08*
Cross-sectional areaa (z) 0.15 *** 0.14 *** 0.03 0.08 *
Section perimeterb (z) 0.22 *** 0.22 *** 0.12*** 0.15***
Length of attachementb (z) 0.20 *** 0.20 *** 0.12*** 0.13***
Cross-sectional areab (z) 0.18 *** 0.18 *** 0.10 ** 0.10**
Volume (z) 0.24 *** 0.23 *** 0.10 ** 0.14***
Table shows Pearson’s correlation coefﬁcients (r) from multiple regression analyses tak
pregnancy, triceps skinfold thickness in late pregnancy and serum 25(OH) Vitamin D in
*p < 0.05, **p < 0.01, ***p < 0.001.
a Measured along the longest edge of attachment to the uterine wall (length).
b Measured perpendicular to the longest edge of attachment to the uterine wall (breause of DXA does not allow for truemeasurement of volumetric bone
density, making it difﬁcult to distinguish relationships with bone
size from those with bone density. Finally, as this was an observa-
tional study it is not possible to be sure about the direction of
associations between placental size and offspring bone mass, and
whether they represent causal relationships; the lack of detailed
physiological data also meant that we were unable to positively
delineate effects of placental size and placental function.usting for potentially confounding maternal inﬂuences.
gth (cm2)
Size corrected
BMC (g/cm2)
Total lean (g) Total fat (z) %Lean (z) %Fat (z)
r r r r r
0.05 0.14 *** 0.14 *** 0.12 *** 0.12 **
0.04 0.11 ** 0.12 ** 0.10** 0.09**
0.01 0.15 *** 0.16 *** 0.14 *** 0.14 ***
0.02 0.19 *** 0.20 *** 0.17*** 0.17 ***
0.03 0.16 *** 0.18 *** 0.16 *** 0.16 ***
0.04 0.18 *** 0.16 *** 0.15 *** 0.14 ***
0.003 0.22 *** 0.23 *** 0.20 *** 0.19 ***
ing account of maternal height, smoking in late pregnancy, walking speed in late
late pregnancy as confounders.
dth).
Table 4
Relationship between maternal characteristics and placental volume.
Placental volume adjusted for gestation (z)
b (95% CI) p Mutually adjusted b (95% CI) p
Age (SD) 0.07 (0.008e0.13) 0.03 0.01 (0.008e0.12) 0.09
Height (SD) 0.09 (0.02e0.15) 0.01 0.08 (0.01e0.14) 0.02
Parity, 2 groups 0.12 (0.01e0.24) 0.07 0.10 (0.03e0.23) 0.14
Walking speed pre-pregnancy (5 groups) 0.003 (0.09e0.08) 0.95 0.03 (0.12e0.06) 0.50
Body fat pre-pregnancy (SD) 0.11 (0.05e0.17) 0.001 0.09 (0.03e0.16) 0.004
Smoking in pregnancy (Yes/No) 0.11 (0.07e0.29) 0.23 0.12 (0.06e0.30) 0.19
Social class (6 groups) 0.01 (0.02e0.05) 0.45 0.03 (0.03e0.09) 0.29
Table shows regression coefﬁcient (95% conﬁdence interval) and mutually adjusted regression coefﬁcient from univariate and multiple regression analyses respectively. Bold
type denotes p < 0.05.
C.R. Holroyd et al. / Placenta 33 (2012) 623e629628Several studies have investigated the association between birth
weight and placental size at various points in gestation. Placental
volume measured by 3D ultrasound scanning in the ﬁrst trimester
was positively associated with birth weight in one study of 199
women [13]. Likewise, placental volume derived from ultrasound
measurements in mid-pregnancy and by direct measurement at
birth have been shown to correlate positively with birth weight
[14e17]. The rate of placental growth appears to be an important
determinant of birth weight, with the rate between 17 and 20
weeks gestation being a predictor of fetal abdominal and head
circumference, femoral length and biparietal diameter; weaker
associations are observed for placental growth earlier in pregnancy
(at 14e17 weeks) [18].
The size, weight and shape of the placenta are all subject towide
variations [19], and growth along one axis may be controlled
differently from that along the other axis [20]. Growth of the
placenta may be polarised from the time of implantation, and it has
been suggested that growth along the major axis (maximal diam-
eter or placental length) is aligned with the rosto-caudal axis of the
embryo, whereas tissue along the minor axis (breadth) may be
more important for transfer of nutrient to the fetus and may be
more sensitive to the mother’s nutrition [20]. Thus, the human
fetus may attempt to compensate for under-nutrition by expansion
of the placenta along its minor axis. Pre-eclampsia, which is asso-
ciated with reduced placental size, is an example of this. Placentas
from pregnancies complicated by pre-eclampsia have increased
thickness due to a reduction in breadth, with no signiﬁcant asso-
ciation with length [21]. In our study, length of attachment to the
uterine wall, section perimeter and cross-sectional area measured
along both axis, were equally associated with offspring BA and
BMC. These placental measurements, when taken transversely
along the minor axis, were also associated with neonatal aBMD; in
contrast, no association with aBMD was seen when the placenta
was measured along its longest axis (length). This may suggest that
growth along the minor axis may be more important for nutrient
transfer and capacity for mineralisation.
Nutrient transport is one of the many functions of the placenta.
Up to 30 g of calcium crosses to the fetus in a successful pregnancy;
in the third trimester calcium transport quadruples to around
140 mg/kg per day to sustain adequate mineralisation of the fetal
skeleton [7]. Placental calcium transport occurs in the synctio-
trophoblast [22]; calcium crosses the placenta bound to calcium
transport proteins including calbindin-D9K and calnexin before
being actively extruded from the basal plasma membrane of the
trophoblast layer to the fetal circulation via a number of pumps and
exchangers, such as Naþ/Ca2þ exchanger and plasma membrane
Ca2þ-ATPase. This last group of transport proteins includes four
individual isoforms (PMCA 1e4) [22]. It has previously been
demonstrated in animal models that a 2e3 fold increase in PMCA
gene expression is associated with a 72-fold increase in calcium
transport across the placenta in late gestation [23].Maternal 25 (OH) vitamin D concentration appears to inﬂuence
offspring bone mineral accrual though effects on the concentration
of umbilical venous calcium [6], and it is possible that regulation of
placental transport may be important in the relationships between
placenta and offspring bone mass. Indeed we have previously
shown that expression of PMCA 3was positively related to neonatal
whole body BMC [9], and several studies have demonstrated the
importance of nutrient transport across the placenta, even after
adjustment for overall size. Maternal vitamin D concentration may
exert its effects on offspring bone mass through PMCA 3 expression
[9], however mechanistic conﬁrmation is required to determine
whether the effects are due to altered presentation of nutrient to
the placenta (substrate dependent) or a direct action on transport
processes. It is difﬁcult to distinguish between the two potential
mechanisms, and our results would be consistent with either,
rather than an effect purely on placental size per se.
The strongest associations detected in our study were between
placental size and neonatal skeletal size. Placental volume pre-
dicted neonatal BA and BMC more strongly than aBMD and scBMC.
This ﬁnding is consistent with previous studies showing that
skeletal size, rather than volumetric density is inﬂuenced by early
life factors. Density tends to be more dependent on environmental
inﬂuences later in the life course, such as loading and nutrition
[2,24]. However, in adult studies, bone size and BMC perform well
as predictors for fracture risk suggesting that the overall size of the
skeletal envelope will have longer term implications.
Thus, recent work has suggested that peak bone mass is a criti-
cally important determinant of osteoporosis in later life [1] and we
have previously demonstrated that early growth predict adult bone
mass [2,3] and risk of hip fracture in later life [4]. We have found
that for every 1 SD increase in placental volume, neonatal BMC
increases by 3.6 g. Placental volume accounted for 6.25% of the
variation in BMC and 1.2% in the variation of BMD at birth. Although
these associations appear modest, they are potentially biologically
signiﬁcant: the difference in mean BMC or BMD for those individ-
uals who were in the top compared with bottom quartile of
placental volume at 19 weeks was 0.7 SD and 0.3 SD respectively. If
these differences were to be sustained into adulthood, they might
equate to a 15% difference in risk of fracture [25]. This ﬁgure is
similar to the 13% increased risk of vertebral fractures in women
who smoke [a risk factor incorporated into the standard interna-
tional method of risk stratiﬁcation (FRAX) [26]] compared to
womenwho do not. Therefore our ﬁndings may well be relevant in
terms of later bone health.
5. Conclusions
In conclusion, we have demonstrated that placental size
measured in mid-pregnancy by ultrasound predicts neonatal bone
mass and body composition, independently of maternal factors
known to inﬂuence neonatal bone mass (parity, smoking, walking
C.R. Holroyd et al. / Placenta 33 (2012) 623e629 629speed, maternal serum 25(OH) vitamin D and maternal triceps
skinfold thickness in pregnancy). These ﬁndings would be consis-
tent with these factors acting through modulation of aspects of
placental function, such as utero-placental blood ﬂow or maternal
nutrient concentrations, rather than placental size; this observation
requires positive demonstration in further studies. Low placental
volume early in pregnancy may be a marker of a smaller postnatal
skeletal size and potentially increased risk of fracture in older age.Funding sources
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